 Nicole Draper
Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chimerism | 2 | 2021 | 29 | 1.020 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2021 | 99 | 0.660 |
Why?
| | Leukocytes | 1 | 2021 | 303 | 0.640 |
Why?
| | Blood Component Removal | 2 | 2016 | 26 | 0.620 |
Why?
| | Blood Grouping and Crossmatching | 3 | 2021 | 14 | 0.510 |
Why?
| | Lipoprotein(a) | 1 | 2016 | 67 | 0.480 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 591 | 0.450 |
Why?
| | Thrombosis | 1 | 2016 | 323 | 0.390 |
Why?
| | Erythrocyte Transfusion | 2 | 2024 | 181 | 0.310 |
Why?
| | Cyclins | 1 | 2008 | 85 | 0.290 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2008 | 46 | 0.290 |
Why?
| | Histocompatibility Testing | 1 | 2008 | 120 | 0.290 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2007 | 28 | 0.280 |
Why?
| | Exanthema | 1 | 2007 | 73 | 0.270 |
Why?
| | Stem Cell Transplantation | 1 | 2008 | 165 | 0.270 |
Why?
| | Electronic Health Records | 2 | 2024 | 973 | 0.270 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 431 | 0.240 |
Why?
| | Cell Nucleus | 1 | 2008 | 579 | 0.240 |
Why?
| | Biological Products | 2 | 2024 | 198 | 0.230 |
Why?
| | Platelet Transfusion | 1 | 2024 | 59 | 0.220 |
Why?
| | ABO Blood-Group System | 1 | 2022 | 39 | 0.200 |
Why?
| | Biomarkers, Tumor | 1 | 2008 | 1175 | 0.190 |
Why?
| | Sialic Acid Binding Ig-like Lectin 3 | 1 | 2021 | 9 | 0.180 |
Why?
| | CD56 Antigen | 1 | 2021 | 37 | 0.180 |
Why?
| | CD3 Complex | 1 | 2021 | 101 | 0.180 |
Why?
| | Bone Marrow | 1 | 2021 | 267 | 0.160 |
Why?
| | Blood Transfusion | 1 | 2021 | 291 | 0.160 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1020 | 0.150 |
Why?
| | Medical Records Systems, Computerized | 1 | 2016 | 93 | 0.130 |
Why?
| | Incidence | 1 | 2022 | 2614 | 0.120 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2016 | 34 | 0.120 |
Why?
| | Catheterization, Central Venous | 1 | 2016 | 97 | 0.110 |
Why?
| | Humans | 12 | 2024 | 128020 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 1 | 2016 | 379 | 0.100 |
Why?
| | Adult | 6 | 2024 | 35177 | 0.100 |
Why?
| | Middle Aged | 5 | 2024 | 30813 | 0.090 |
Why?
| | Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2010 | 2 | 0.090 |
Why?
| | Colonic Diseases | 1 | 2010 | 32 | 0.090 |
Why?
| | Male | 6 | 2024 | 62758 | 0.080 |
Why?
| | Cyclin D3 | 1 | 2008 | 5 | 0.080 |
Why?
| | Retinoblastoma Protein | 1 | 2008 | 54 | 0.080 |
Why?
| | Leukemia, Myelomonocytic, Acute | 1 | 2008 | 7 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 71 | 0.080 |
Why?
| | Ki-67 Antigen | 1 | 2008 | 107 | 0.070 |
Why?
| | HLA-C Antigens | 1 | 2008 | 35 | 0.070 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 205 | 0.070 |
Why?
| | HLA-B Antigens | 1 | 2008 | 62 | 0.070 |
Why?
| | Colonic Neoplasms | 1 | 2010 | 242 | 0.070 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2007 | 7 | 0.070 |
Why?
| | Dilatation, Pathologic | 1 | 2007 | 60 | 0.070 |
Why?
| | Microsatellite Repeats | 1 | 2008 | 161 | 0.070 |
Why?
| | Capillaries | 1 | 2007 | 91 | 0.070 |
Why?
| | Haplotypes | 1 | 2008 | 471 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2008 | 771 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2022 | 14404 | 0.060 |
Why?
| | Blood Banks | 1 | 2024 | 40 | 0.060 |
Why?
| | Biopsy | 1 | 2007 | 1077 | 0.050 |
Why?
| | Skin | 1 | 2007 | 711 | 0.050 |
Why?
| | Female | 5 | 2024 | 68017 | 0.050 |
Why?
| | Aged | 3 | 2024 | 21892 | 0.050 |
Why?
| | Blood Platelets | 1 | 2024 | 376 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2021 | 79 | 0.050 |
Why?
| | Erythrocytes | 1 | 2024 | 673 | 0.040 |
Why?
| | Hemorrhage | 1 | 2021 | 643 | 0.030 |
Why?
| | United States | 2 | 2024 | 13785 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5353 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2008 | 7029 | 0.030 |
Why?
| | Veins | 1 | 2016 | 58 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2016 | 315 | 0.030 |
Why?
| | Health Surveys | 1 | 2016 | 491 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2016 | 248 | 0.030 |
Why?
| | Tissue Donors | 1 | 2016 | 388 | 0.030 |
Why?
| | Societies, Medical | 1 | 2016 | 741 | 0.020 |
Why?
| | Hemangioma | 1 | 2010 | 43 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1408 | 0.020 |
Why?
| | Head and Neck Neoplasms | 1 | 2010 | 532 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 20158 | 0.010 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 487 | 0.010 |
Why?
|
|
Draper's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|